Product Information
ERYTHROMYCIN 400 MG/5 ML SUSP is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $1.7573 per ML under NDC 75834029401. Its NADAC has been published 164 times since May 10, 2023.
Strength
400 mg/5mL
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834029401
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA216212On Market Since
2/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has been published 164 times since May 10, 2023, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7573 per ML |
|---|---|
| All-time high | $2.7783 (Apr 10, 2024) |
| All-time low | $1.7573 (Jun 17, 2026) |
| 52-week high | $2.2830 |
| 52-week low | $1.7573 |
| Median price | $2.0426 |
| Average price | $2.1940 |
| Largest weekly change | -20.3% (Apr 17, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 400 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 400 MG/5 ML SUSP, manufactured by Nivagen Pharmaceuticals Inc., is $1.7573 per ML (NDC 75834029401), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 400 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has declined 34.6%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 400 MG/5 ML SUSP?
Since May 10, 2023, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has ranged from a low of $1.7573 (Jun 17, 2026) to a high of $2.7783 (Apr 10, 2024), with a median of $2.0426 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 400 MG/5 ML SUSP?
4 NADAC-published products share the same active ingredient, strength, and dosage form as ERYTHROMYCIN 400 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 400 MG/5 ML SUSP?
ERYTHROMYCIN 400 MG/5 ML SUSP (NDC 75834029401) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification